Circumventing Previa at Hysterotomy Creation ...

As healthcare professionals, we should all seek and encourage scientific and medical discovery and new therapies. That’s one big goal of the scientific process: to bring new therapies to otherwise lethal condition. For example, back in the 80s and 90s, HIV uniformly led to AIDS, ...  Show more

In 2018, the ARIVE trial was published in the NEJM revealingthat induction of labor at 39 weeks reduced cesarean deliveries and gestational hypertension/preeclampsia in low-risk nulliparous women who had labor induced,compared to expectant management. Then, in 2025, and partly in ...  Show more

Content Warning: This episode includes mentions of miscarriage, pregnancy loss, pregnancy complications, traumatic birth experiences, and other potentially disturbing topics related to childbirth, pregnancy, and the postpartum period. In Act 3 of our pregnancy series, we arrive a ...  Show more

Dr. Adam Striker and Dr. Alyssa Brzenski, editor for Summaries of Emerging Evidence (SEE), examine two recent studies featured in the 40A issue. Listen in as they discuss a study of the use of a prophylactic methylergonovineduring intrapartum cesarean birth, and a second study ...

In this episode, we review the high-yield topic of Placenta Previa from the Obstetrics section.

Follow <a href="h ...

ACOG Practice bulletin: # 171 PTL or TPTL:  Preterm <37wks, cervical change Evaluation: SSE first: Collect GC/CT cultures, FFN (no gel, blood or semen), GBS, eval for rupture if needed SVE: Cervical change–can dilation or effacement changes FFN: Fetal fibronectin If tPTL: Magnesi ...  Show more